GeoPolitics Pulse

The Heartbeat of World events

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in …

by ·

PRNewswire/ — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,.Read More

Related posts:

  1. Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in …
  2. Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in …
  3. Eisai Gets Positive Opinion From CHMP In European Union For Lecanemab In Early … – Nasdaq
  4. Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
  5. Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union